Another of our deep-in-the-weeds theranostic webinars in conjunction with our friends at ProsTiC, and the Prostate Cancer Foundation. This one focussed on Terbium-161, a very exciting new option in metastatic prostate cancer. Your hosts are Dr Renu Eapen and Professor Michael Hofman, with Dr Howard Soule and Dr Andrea Miyahira from the Prostate Cancer Foundation. Special guests include Dr James Buteau (Peter Mac, Melbourne, Australia), Dr Alin Chirindel (Universitätsspital Basel), Prof Dr Samer Ezziddin (Saarland University Hospital, Germany) and Prof. Cristina Müller (Paul Scherrer Institute, Switzerland)Is Terbium-161 superior to Lutetium-177? You'll hear about the latest clinical trials, experience and translational research from world leaders using Terbium-161.Enjoy multi-disciplinary discussion covering nuclear medicine, radiopharmaceutical sciences, medical oncology, urology, radiation oncology, medical physics, translational sciences & industry.Even better on our YouTube channel

Ver todos los episodios